.svg){kind=small}
Oct-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Is this your brand?
See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.
See your brand's dataCarry this brand in your store?
Headset Retailer is free. Connect your POS and see what's selling and what's sitting.
Sign up freeWhere to Buy
Chronic Health is stocked at 37 licensed dispensaries across Arizona, with the deepest coverage in Phoenix, Mesa, Kingman, Sun City, and Tucson. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In October 2026, Chronic Health concentrated 74.58% of sales in Topical, where unit revenue moved with a 3.50% YoY price lift to an average of $21.81 while category sales fell 42.36% YoY and 4.98% MoM; Tincture & Sublingual comprised 25.42% share with a 65.28% YoY and 43.80% MoM decline alongside a lower average price point at $13.32. This mix, paired with a brand-level 50.64% YoY sales contraction and a 59.94% 24‑month slide, indicates the brand is anchored to a shrinking Topical base that is softening less rapidly MoM than Tincture & Sublingual, implying that near‑term stability depends on maintaining Topical depth in Arizona.
Holding rank 3 in Topical within Arizona despite a 42.36% YoY decline and only a 4.98% MoM dip suggests relative insulation in its primary category, while the 25.42% mix exposure to Tincture & Sublingual is dragging overall trajectory with a 43.80% MoM drop and 65.28% YoY fall. The pattern implies Chronic Health’s positioning skews toward defensible share within Topical but dilutive breadth in Tincture & Sublingual, so concentrating assortment and activation where rank 3 is established can mitigate the 50.64% YoY brand contraction while de‑emphasizing underperforming sublingual formats reduces volatility risk.
Competitive Landscape
Chronic Health is ranked #3 in AZ Topical in October 2026, unchanged year over year at #3 but down 1 position from July 2026 when it sat at #2; that stability contrasts with iLava rising from #5 to #2 while posting a -4.7% year-over-year sales change and Drip Oils + Extracts holding #1 with a +14.4% year-over-year sales gain, while Gramz slipped from #6 to #4 alongside a -17.8% decline; given Chronic Health’s prior peak at #1 in March 2025 and its 1-rank drop in the last three months, the pattern implies a stable but ceding position where regaining share likely requires reversing recent quarter-on-quarter rank pressure against faster-moving incumbents.
Notable Products
Chronic Health is concentrated in Topical formats, with Lotion, Salves, Gels, and Creams accounting for 74.6% of October 2026 sales while Tinctures make up 25.4%. The lineup leans on a few pain-relief SKUs like CBD/THC 1:1 Pain Relief Ointment, so most of its sales come from topical remedies rather than drops.
Peer avg: average price of the same product type and package size in the same states that month.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
